0001209191-19-061050.txt : 20191217 0001209191-19-061050.hdr.sgml : 20191217 20191217200214 ACCESSION NUMBER: 0001209191-19-061050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191213 FILED AS OF DATE: 20191217 DATE AS OF CHANGE: 20191217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cumbo Alexander CENTRAL INDEX KEY: 0001685994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 191291088 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-13 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001685994 Cumbo Alexander 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 EVP, Chief Commercial Officer Common Stock 2019-12-13 4 M 0 2727 13.71 A 13888 D Common Stock 2019-12-13 4 M 0 3895 13.71 A 17783 D Common Stock 2019-12-13 4 M 0 26084 26.24 A 43867 D Common Stock 2019-12-13 4 S 0 32706 125.50 D 11161 D Common Stock 2019-12-13 4 S 0 9294 125.50 D 1867 D Common Stock 3441 I By grantor retained annuity trust Stock option (right to buy) 13.71 2019-12-13 4 M 0 2727 0.00 D 2016-09-09 2026-02-28 Common Stock 2727 1123 D Stock option (right to buy) 13.71 2019-12-13 4 M 0 3895 0.00 D 2017-02-28 2026-02-28 Common Stock 3895 0 D Stock option (right to buy) 26.24 2019-12-13 4 M 0 26084 0.00 D 2014-01-02 2023-01-02 Common Stock 26084 20881 D This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. /s/ David Tyronne Howton, as Attorney-in-Fact for Alexander Cumbo 2019-12-17